PYRAZOLO[1,5-a]PYRIDINE COMPOUND AND ITS MEDICINE

PROBLEM TO BE SOLVED: To provide a CRF receptor antagonist which meets the points of pharmacological activity, dosage, safety and the like and effectively acts in clinical trials. SOLUTION: The compound is represented by formula (I) (wherein R1is a methoxy group, an ethyl group, a methylthio group o...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	HIRAKAWA TETSUYA, SHIBATA HISASHI, HOSHINO TAKEHISA, TAKAHASHI YOSHINORI, KIKUCHI KOICHI, INO MITSUHIRO, SOEJIMA HIROYOSHI, ONO ATSUKO, SHIN MITSUTAMA, YOSHIUCHI TATSUYA, HIBI SHIGEKI
Format:	Patent
Sprache:	eng
Schlagworte:	ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	PROBLEM TO BE SOLVED: To provide a CRF receptor antagonist which meets the points of pharmacological activity, dosage, safety and the like and effectively acts in clinical trials. SOLUTION: The compound is represented by formula (I) (wherein R1is a methoxy group, an ethyl group, a methylthio group or the like; R2, R3, and R4are each hydrogen, a halogen or the like; R5and R6are each a group represented by the formula: -X5-X6-X7; and Ar is a phenyl group, a pyridyl group or the like) and includes its salt and a hydrate thereof. COPYRIGHT: (C)2009,JPO&INPIT